Venture Life Group plc
Established in Bracknell, UK, in 2005, Venture Life Group plc is an international developer and marketer of diverse health and personal care items. The company's portfolio spans oral care products, dietary supplements, medical devices, dermo-cosmetics, and topical applications, serving a global market across the…
1D
+0.0%
1W
+0.0%
1M
+0.7%
6M
+5.3%
YTD
+4.5%
1Y
+20.5%
2Y
+64.3%
5Y
+42.3%
10Y
+30.4%
Next earnings date
28/02/2027 (in 134 days)
Volatility around earnings
~9% stronger price swings than usual
P/E
15.83
P/B
1.09
EV/EBITDA
9.52
RETURN ON EQUITY
9.3%
NET MARGIN
38.4%
DEBT/EQUITY
0.01
DIVIDEND YIELD
0.0%
AS OF
31/12/2025
FREE FLOAT
88.4%
FLOAT SHARES
104,970,723
AVG. DAILY VOLUME (30D)
294,355
Venture Life Group plc is a company in the Healthcare sector, Medical - Pharmaceuticals industry, headquartered in United Kingdom.
The CEO is Jeremy Anthony Philip Randall, the company employs around 63 people.
The IPO was on 28/03/2014; the stock trades on LSE under the ticker VLG.L.
The next earnings date is 28/02/2027.
Around past earnings, price swings were roughly 9% stronger than usual.
Yes. The last dividend was £0.04 per share, ex-date 24/05/2018, paid on 22/06/2018.
The dividend yield is 0.0% (as of 31/12/2025).
Comparable stocks include Corcept Therapeutics, Liquidia, Latigo Biotherapeutics, Helus Pharma, GSK, Smith & Nephew, ConvaTec Group and LivaNova.
Clicking "Analyze stock" lets five strategies assess Venture Life Group against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.